Malignant mesothelioma: risk factors and current management

Related Experiment Video

Updated: Aug 24, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Ruth Dunleavey1

  • 1St Vincent's Hospital, Sydney, Australia.

Nursing Times
|May 11, 2004
PubMed

Insights

Malignant mesothelioma, a rare cancer linked to asbestos, is increasing due to long latency. This review covers its causes, management, and UK patient resources.

Area of Science:

  • Oncology
  • Public Health

Background:

  • Malignant mesothelioma is a rare cancer affecting the pleura and peritoneum.
  • Asbestos exposure is a primary risk factor, with a significant latency period.
  • Incidence is rising, necessitating comprehensive understanding and management.

Purpose of the Study:

  • To provide a comprehensive review of malignant mesothelioma.
  • To detail the disease process, risk factors, and etiological agents.
  • To outline current management strategies and available patient resources.

Main Methods:

  • Literature review of malignant mesothelioma.
  • Analysis of disease process, risk factors, and causes.
  • Summary of current treatment modalities and support systems.

Main Results:

  • Malignant mesothelioma is strongly associated with asbestos exposure.
  • The disease has a long latency period, contributing to increasing incidence.
  • Multimodal treatment approaches including surgery, chemotherapy, and radiotherapy are employed.

Conclusions:

  • Effective management requires understanding the disease's progression and risk factors.
  • Multidisciplinary care and patient support are crucial for mesothelioma patients.
  • Further research and awareness are needed to combat this asbestos-related cancer.

More Related Videos

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations: